Citation Impact
Citing Papers
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
2009
Sepsis biomarkers: a review
2010 Standout
Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum
2015 StandoutNobel
Increased Caffeine Consumption Is Associated With Reduced Hepatic Fibrosis
2009
Repression of New p53 Targets Revealed by ChIP on Chip Experiments
2006
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Mechanotransduction and extracellular matrix homeostasis
2014 Standout
Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.
2018
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients
2015
HCVpro: Hepatitis C virus protein interaction database
2011
Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro
2010
p63 and epithelial biology
2006
Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient mice
2009
Hepatocellular carcinoma
2021 Standout
Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury
2008
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Hepatocellular carcinoma: Mouse models and the potential roles of proteases
2016
Metazoan MicroRNAs
2018 Standout
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study
2015
Acute kidney injury
2019 Standout
Evolving challenges in hepatic fibrosis
2010
New Insights into the Regulation of Epithelial–Mesenchymal Transition and Tissue Fibrosis
2012
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C
2007
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
2013
p53 in health and disease
2007 Standout
A comprehensive overview of exosomes as drug delivery vehicles — Endogenous nanocarriers for targeted cancer therapy
2014
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Biological Gene Delivery Vehicles: Beyond Viral Vectors
2009
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
EMT: 2016
2016 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Pyroptosis: A new frontier in cancer
2019 Standout
The p53 family in nervous system development and disease
2006
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice
2008
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
2010
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates
2009
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
2011 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C # ∥ ‡
2009
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Cellular senescence: from physiology to pathology
2014 Standout
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
2012
Kidney-Immune System Crosstalk in AKI
2018
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Physiology and Pathophysiology of Carnosine
2013 Standout
IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-β–Independent Smad Signaling
2011
Single nucleotide polymorphisms of complement component 5 and periodontitis
2009
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Effect of carnosine against thioacetamide-induced liver cirrhosis in rat
2009
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Transcriptional control of human p53-regulated genes
2008 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
2013
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
p63 regulates glutaminase 2 expression
2013
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Involvement of cAMP-PKA pathway in adenosine A1 and A2A receptor-mediated regulation of acetaldehyde-induced activation of HSCs
2015
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma
2014
Works of O Gressner being referenced
Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients
2009
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis
2009
Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
2008
High C5a levels are associated with increased mortality in sepsis patients — No enhancing effect by actin-free Gc-globulin
2008
Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression
2008
Increased serum xylosyltransferase activity in patients with liver fibrosis
2009
Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways
2008
Gc-globulin concentrations and C5 haplotype-tagging polymorphisms contribute to variations in serum activity of complement factor C5
2007
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
2008
Less Smad2 is good for you! A scientific update on coffee's liver benefits #
2009
Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice
2008
Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre‐disposition pending between fiction and reality
2007
Evaluation of hepatotropic targeting properties of allogenic and xenogenic erythrocyte ghosts in normal and liver‐injured rats
2007
Genetic Determinants in Hepatic Fibrosis: From Experimental Models to Fibrogenic Gene Signatures in Humans
2008
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options
2007
Differential effects of TGF-β on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes
2007
Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: Relationship to S-100B levels and blood–brain barrier function
2008
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
2005
Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor β actions in hepatocytes—But without modulating bone morphogenetic protein 7 signaling†
2009
Connective Tissue Growth Factor in Serum as a New Candidate Test for Assessment of Hepatic Fibrosis
2006
Gc-Globulin: Roles in Response to Injury
2006